Company intelligence / Profile preview

Nomax

St. Louis, Missouri, United States
Ownership
Private
Employees
~55
Development stage
Other
01

Overview

Nomax is a privately held U.S. specialty pharmaceutical manufacturer focused on prescription and over-the-counter effervescent products, liquid formulations, medical devices, and selected dietary supplements. The company is best known for manufacturing effervescent potassium products such as Effer-K and for providing contract development and manufacturing services to other pharmaceutical companies. Nomax appears to operate primarily as a commercial-stage manufacturer rather than a clinical-stage drug developer, with capabilities spanning oral solid dosage, non-sterile liquids, packaging, and diagnostic strip products. Its business model combines its own niche branded or marketed products with fee-for-service manufacturing and formulation support for external customers.

Therapeutic areas
EndocrinologyOphthalmology
Modalities
Small moleculeDevice
Industry
Biotech

Beyond the preview

Go deeper on Nomax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nomax.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call